경력사항
2020. 서울시 공공보건의료재단 위촉연구원
2019 University of Strathclyde, 약학대학(SIPBS), Glasgow, UK, 방문연구원
2016 목원대학교 의생명보건학부
2014 Harvard TH. Chan School of Public Health, Boston, USA, Post-Doc
2012 서울대학교 보건대학원 보건환경연구소, 연구교수
2006 국민건강보험공단
Pharmacoeconomics-open(SCI), Editorial Board
Frontiers in Pharmacology(SCIE), Editor
보건사회약료경영학회 이사
2024년 국민건강보험공단 빅데이터 전문위원
2023년 국민건강보험공단 빅데이터 전문위원
(전) ISPOR Korea Chapter, 부회장
(전)국민건강보험공단 급여전략자문위원
(전)건강보험심사평가원 자문위원
(전)한국보훈의료복지공단 자문위원
(전)식품의약품안전처 중앙약사심의위원
(전)2020년 더불어민주당 포용복지국가위원회 위원
<저서>
Yang BM and Kwon HY(2013), TRIPS and New Challenges for Pharmaceutical Sector in South Korea. In : Hans Lofgren, Owain David Williams, The New Political Economy of Pharmaceuticals : Production, Innovation and TRIPS in the Global South Palgrave Macmillan ISBN:978-0-230-28463-0
Godman B, Kwon HY, Bennie M, Amarsdttir A(2016), Introduction to drug utilisation and pharmaceutical policy. In : Monique Elseviers et al, Drug Utilization Research : Methods and Applications Wiley Blackwell ISBN:978-1-118-94978-8
Kwon HY and Kim YJ(2020) Global access to Cancer medicines In: ZUD Barber, Global Pharmaceutical Policyalgrave MacMillan ISBN : 978-981-15-2724-1
< 논문 : 2022 ~ >
1. 권혜영, 오수현, 한국의료패널자료를 활용한 건강기능식품섭취에 따른 의료비지출 비교분석 보건행정학회 2024 [주저자 및 교신저자]
2. Woo H, Shin G, Lee D, Kwon HY, Bae S. Is the Availability of Biosimilar Adalimumab Associated with Budget Savings? A Difference-in-Difference Analysis of 14 Countries. BioDrugs. 2023 Dec 8. doi: 10.1007/s40259-023-00636-z. Epub ahead of print. PMID: 38064144. [교신저자]
3. Kwon HY, Who persistently consumes dietary supplements? A multifaceted analysis using South Korea’s nationally representative health and nutrition examination survey data, Frontiers in Nutrition 2023;10:124367 [단독저자]
4. 김설인, 편도윤, 정용익, 조자현, 노가야, 배그린, 권혜영, AHP를 활용한 개인용 체외진단의료기기 분류기준 우선순위조사, 보건행정학회지 2023;33(2):173-184 [교신저자]
5. Kim HM, Godman B, Kwon HY, Hong SH, Introudction of managed entry agreements in Korea : Problem, Policy and Politics Frontiers in Pharmacology 2023:14:1150055 [교신저자]
6. Kwon HY, Godman B, (Editorial) Pharmceutical policy, impact and Health outcomes, Frontiers in Pharmacology 2023;14:999220 [주저자]
7. Kwon HY, Kim Yongjoo, Lee SY, Kim CB, Quarantining: A Mentally Distressful but Physically Comfortable Experience in South Korea, Health and Quality of Life Outcomes 2022;20:144 [주저자]
8. 권혜영, 처방의 질 향상을 통한 의약품 비용규제에 대한 제언, 한국보건사회약료경영학회지 2022;10(1):1-3 [단독저자]
9. Lee HJ, Han JY, Hwang JH, Kwon HY, Choi HZ, Association between preterm premature rupture of membranes and vitamin D levels in maternal plasma and umbilical cord blood of newborns: A prospective study, Clinical and Experimental Obstetrics & Gynecology 2022;49(7):158 [공저자]
10. Lee Hyunji, Koh JW, Kim YA, Chun KC, Han JY, Hwang JH, Choi JS, Joo SH, Kwon HY, Pregnancy and neonatal outcomes after exposure to alprazolam in pregnancy, Frontiers in Pharmacology 2022 13:854562. doi: 10.3389/fphar.2022.854562 [교신저자]
11. Shin G, Kwon HY, Bae SJ, For Whom the Price Escalates: High Price and Uncertain Value of Cancer Drugs Int. J. Environ. Res. Public Health 2022, 19, 4204. https://doi.org/10.3390/ijerph19074204 [공저자]
12. Godman B. et al, Biosimilars are essential for sustainable healthcare systems; however, key challenges remain as seen with long-acting insulin analogues, Journal of Applied Pharmaceutical Science 2022;12(3):55-72 [공저자]
13. Kwon HY, Kim Y, Lee SY, Kim CB, What matters for Depression and Anxiety During the COVID-19 Quarantine? Frontiers in Psychiatry 2022:13;706436 [주저자 및 교신저자]
14. Kim Y, Lee SY, Kwon HY, Depression During COVID-19 Quarantine in South Korea, Frontiers in Public Health 2022;9:743625 [교신저자]
